FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to the field of medicine, namely to pharmacology and describes a pharmaceutical composition for the local treatment of psoriasis, which includes calcipotriol or calcipotriol monohydrate as an active component, a water-free lipid carrier and a three-component isotropic dissolving mixture, containing 30-60 wt % of a hydrophilic non-ionogenic surface-active substance, 20-40% of a lipophilic non-ionogenic additional surface-active substance and 15-40 wt % of C6-22 acylglyceride.
EFFECT: invention can be applied for the treatment of psoriasis, as well as for supporting processing of the patients' skin after the disappearance of visible symptoms to prevent disease manifestation symptoms.
23 cl, 5 dwg, 9 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING VITAMIN D ANALOGUE AND MIXED CO-SOLVENT AND SURFACTANT | 2009 |
|
RU2500387C1 |
PHARMACEUTICAL COMPOSITION, INCLUDING DISSOLVING MIXTURE AND VITAMIN D DERIVATIVE OR ANALOGUE | 2010 |
|
RU2559084C2 |
PHARMACEUTICAL AEROSOL FORMULATION CONTAINING VITAMIN D ANALOGUE AND CORTICOSTEROID | 2011 |
|
RU2576607C2 |
COMPOSITION CONTAINING LIPID NANOPARTICLES AND CORTICOSTEROID OR VITAMIN D DERIVATIVE | 2012 |
|
RU2602171C2 |
POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D AND CORTICOSTEROID | 2008 |
|
RU2466716C2 |
COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION | 2009 |
|
RU2497506C2 |
OINTMENT COMPOSITION CONTAINING VITAMIN D DERIVATIVE | 2007 |
|
RU2448713C2 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
RACECADOTRIL LIPID COMPOSITIONS | 2014 |
|
RU2662069C2 |
CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS | 2010 |
|
RU2555339C2 |
Authors
Dates
2015-08-20—Published
2010-12-22—Filed